Breakthrough Therapy Designation: FDA Fast-Tracks AbbVie’s Temab-A in Two Cancers
The FDA gave AbbVie's experimental drug Temab-A two breakthrough therapy designations in colorectal and lung cancer. It speeds development, but it is not an approval.
AbbVie
Local weather
Finding your area…National Weather Service
Trending
- College Football Week 6 Guide: Georgia-Alabama, Red River and Every Big Game to Watch
- Georgia Beats Alabama 20-17 as Hurricane Isaias Soaks Tuscaloosa
- Starbucks Chipotle Takeover Report: Coffee Giant Wouldn’t Say No
- What the La Liga Suspension Means for Rayo and Athletic
- Oklahoma Stuns No. 1 Texas 27-24 on Last-Second Field Goal in Red River Rivalry